Plasminogen activator inhibitor 1 activity and other coronary risk factors

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 1, 2005, Pages 55-61

  Von Eyben, Finn Edler ^a,f   Mouritsen, Ejvind ^a   Holm, Jan ^a   Montvilas, Paulius ^a   Dimcevski, Georg ^a   Suciu, Gabriel ^d   Rasmussen, Inger Helleberg ^b   Kristensen, Lisbeth Langholz ^c   Von Eyben, Rie ^e  

^a HERNING HOSPITAL   (Denmark)

^b Tarm Hospital   (Denmark)

^c Varde Hospital   (Denmark)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Center of Tobacco Control Research   (Denmark)

Author keywords

Age; Obesity; Plasminogen activator inhibitor; Triglyceride; Von Willebrand factor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADIPOSE TISSUE; ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEART INFARCTION; HUMAN; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; AGING; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES; VON WILLEBRAND FACTOR;

EID: 13244259342     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100106     Document Type: Article

References (24)

1. Thogersen AM, Jansson JH, Boman K, et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women. Evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998;98:2241.
2. Juhan-Vague I, Pyke SD, Alessi MC, et al. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation 1996;94:2057.
3. Leander K, Wiman B, Hallqvist J, et al. PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction. Results from the Stockholm Heart Epidemiology Program (SHEEP). Thromb Haemost 2003;89:1064.
4. Eliasson M, Evrin PE, Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: The North Sweden MONICA Study. J Clin Epidemiol 1994;47:513.
5. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med 1996;7:800.
6. Sasaki A, Kurisu A, Ohno M, Ikeda Y. Overweight/obesity, smoking, and heavy alcohol consumption are important determinants of plasma PAI-1 levels in healthy men. Am J Med Sci 2001;322:19.
7. von Eyben FE, Mouritsen E, Holm J, et al. Intra-abdominal obesity and metabolic risk factors: A study of young adults. Int J Obes Metab Rel Disord 2003;27:941.
8. von Eyben FE, Mouridsen E, Holm J, et al. Smoking, low density lipoprotein cholesterol, fibrinogen and acute myocardial infarction before 41 years of age: A Danish case-control study. J Cardiovasc Risk 2002;9:171.
9. Stief TW, Lenz P, Becker U, Heimburger N. Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in the presence of oxidants: a novel principle. Thromb Res 1988;50:559.
10. Svalastoga K. Prestige, Class, and Mobility. Copenhagen: Munksgaard, 1959.
11. Hansen EJ. Social Groups in Denmark (Socialgrupper i Danmark). Copenhagen: The Institute of Social Sciences, 1984.
12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998;15:539.
13. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.
14. von Eyben F, von Eyben R. Smoking and other major coronary risk factors and acute myocardial infarction before 41 years of age: Two Danish case-control studies. Scand Cardiovasc J 2001;35:25.
15. Juhan Vague I, Thompson SG, Jespersen J. Involvement of the hemostatic system in insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb 1993;134:865.
16. Vague P, Juhan Vague J, Chabert V, et al. Fat distribution and plasminogen activator inhibitor activity in non-diabetic obese women. Metabolism 1989;38:913.
17. Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary atery disease: Correlations with age and serum triglyceride concentrations. J Am Coll Cardiol 1987;98:263.
18. Sundell B, Nilsson TK, Hallmans G, et al. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. Atherosclerosis 1989;80:9.
19. Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990;227:273.
20. Chadarevian R, Bruckert E, Dejager S, et al. Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: Lack of a threshold value. Thromb Res 1999;96:175.
21. Nilsson TK, Boman K, Bjerle P, et al. von Willebrand factor and fibrinolytic variables are differently affected in the insulin resistance syndrome. J Intern Med 1994;235:419.
22. Eliasson M, Asplund K, Evrin PE, Lundblad D. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study. Metabolism 1994;43:1579.
23. Pannacculi N, De Mitrio V, Marino R, et al. Effects of glucose tolerance on PAI-1 plasma levels in overweight and obese subjects. Obese Res 2002;10:717.
24. He G, Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro. Biochem Biophys Res Commun 2003;310:878.